MONTREAL, Nov. 13 /CNW Telbec/ - Immunotec Inc. (TSX-V IMM) announces
that it has received regulatory approval from Health Canada to market HMS 90 /
IMMUNOCAL with the following health claim: "a natural source of the
glutathione precursor cysteine for the maintenance of a strong immune system."
The Natural Health Products Directorate (NHPD) is Health Canada's
division responsible for the evaluation of the safety, efficacy and quality of
natural health products. It has issued a Natural Product Number (NPN) for
HMS 90 / IMMUNOCAL based on the credibility, strength and quality of evidence
provided to support the claim.
Immunotec strongly supports the implementation of the Natural Health
Products Regulation. President and Chief Executive Officer Jim Northrop notes:
"The imposition of high standards to ensure the quality, safety and efficacy
of natural products supports Immunotec's commitment to excellence in product
development and manufacturing. The issuance of this NPN reinforces to
consumers and Distributors alike that superb scientific evidence is the
foundation for HMS 90 / IMMUNOCAL. This fact, along with the important
associated health claim could have a significant impact on Immunotec's
Senior Vice-President, Research & Development, Dr. Wulf Droge, is
extremely pleased about this regulatory approval. "What consumers have known
for quite some time has now been formally recognized by the NHPD: the health
benefits of Immunotec's lead product HMS 90 / IMMUNOCAL for the immune system
are based on solid science."
Natural Health Products must be manufactured, packaged, and labelled in
Health Canada-approved facilities according to current Good Manufacturing
Practices to ensure optimal quality of the finished goods. The evaluation of
the efficacy of a specific product allows consumers to make an informed choice
when including natural health products in their wellness regimes.
Immunotec operates out of a 37,000 square foot facility located in
Vaudreuil-Dorion, Quebec, Canada as well as a distribution centre located in
Swanton, Vermont, USA. Immunotec is engaged primarily in the development and
marketing of natural health products, dietary supplements, food, vitamins and
personal care products, many of which are manufactured on its behalf by third
parties. Immunotec's products are distributed and sold in Canada and the
United States through a network marketing system and in other countries under
exclusive distributorship agreements.
For further information:
For further information: Media contact: Richard Patte, Executive
Vice-President, (450) 510-4445, firstname.lastname@example.org